Global Diagnostic Radiopharmaceuticals Market Growth 2022-2028
As the global economy mends, the 2021 growth of Diagnostic Radiopharmaceuticals will have significant change from previous year. According to our latest study, the global Diagnostic Radiopharmaceuticals market size is USD million in 2022 from USD 4289.7 million in 2021, with a change of % between 2021 and 2022. The global Diagnostic Radiopharmaceuticals market size will reach USD 6959.8 million in 2028, growing at a CAGR of 7.2% over the analysis period.
The United States Diagnostic Radiopharmaceuticals market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Diagnostic Radiopharmaceuticals market, reaching US$ million by the year 2028. As for the Europe Diagnostic Radiopharmaceuticals landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Diagnostic Radiopharmaceuticals players cover Cardinal Health, GE Healthcare, Curium Pharma, and Jubilant Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Technetium 99
Fluorine 18
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Diagnostic Radiopharmaceuticals by Country/Region, 2017, 2022 & 2028
2.2 Diagnostic Radiopharmaceuticals Segment by Type
2.2.1 Technetium 99
2.2.2 Fluorine 18
2.2.3 Other
2.3 Diagnostic Radiopharmaceuticals Sales by Type
2.3.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2022)
2.3.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Type (2017-2022)
2.3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Type (2017-2022)
2.4 Diagnostic Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Radiopharmaceuticals Sales by Application
2.5.1 Global Diagnostic Radiopharmaceuticals Sale Market Share by Application (2017-2022)
2.5.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Application (2017-2022)
2.5.3 Global Diagnostic Radiopharmaceuticals Sale Price by Application (2017-2022)
3 Global Diagnostic Radiopharmaceuticals by Company
3.1 Global Diagnostic Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Diagnostic Radiopharmaceuticals Annual Sales by Company (2020-2022)
3.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2022)
3.2 Global Diagnostic Radiopharmaceuticals Annual Revenue by Company (2020-2022)
3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Company (2020-2022)
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diagnostic Radiopharmaceuticals Product Location Distribution
3.4.2 Players Diagnostic Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region
4.1 World Historic Diagnostic Radiopharmaceuticals Market Size by Geographic Region (2017-2022)
4.1.1 Global Diagnostic Radiopharmaceuticals Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Diagnostic Radiopharmaceuticals Annual Revenue by Geographic Region
4.2 World Historic Diagnostic Radiopharmaceuticals Market Size by Country/Region (2017-2022)
4.2.1 Global Diagnostic Radiopharmaceuticals Annual Sales by Country/Region (2017-2022)
4.2.2 Global Diagnostic Radiopharmaceuticals Annual Revenue by Country/Region
4.3 Americas Diagnostic Radiopharmaceuticals Sales Growth
4.4 APAC Diagnostic Radiopharmaceuticals Sales Growth
4.5 Europe Diagnostic Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Diagnostic Radiopharmaceuticals Sales Growth
5 Americas
5.1 Americas Diagnostic Radiopharmaceuticals Sales by Country
5.1.1 Americas Diagnostic Radiopharmaceuticals Sales by Country (2017-2022)
5.1.2 Americas Diagnostic Radiopharmaceuticals Revenue by Country (2017-2022)
5.2 Americas Diagnostic Radiopharmaceuticals Sales by Type
5.3 Americas Diagnostic Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Radiopharmaceuticals Sales by Region
6.1.1 APAC Diagnostic Radiopharmaceuticals Sales by Region (2017-2022)
6.1.2 APAC Diagnostic Radiopharmaceuticals Revenue by Region (2017-2022)
6.2 APAC Diagnostic Radiopharmaceuticals Sales by Type
6.3 APAC Diagnostic Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Diagnostic Radiopharmaceuticals by Country
7.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Country (2017-2022)
7.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2017-2022)
7.2 Europe Diagnostic Radiopharmaceuticals Sales by Type
7.3 Europe Diagnostic Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2017-2022)
8.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2017-2022)
8.2 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
10.4 Industry Chain Structure of Diagnostic Radiopharmaceuticals
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Diagnostic Radiopharmaceuticals Distributors
11.3 Diagnostic Radiopharmaceuticals Customer
12 World Forecast Review for Diagnostic Radiopharmaceuticals by Geographic Region
12.1 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Diagnostic Radiopharmaceuticals Forecast by Region (2023-2028)
12.1.2 Global Diagnostic Radiopharmaceuticals Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Diagnostic Radiopharmaceuticals Forecast by Type
12.7 Global Diagnostic Radiopharmaceuticals Forecast by Application
13 Key Players Analysis
13.1 Cardinal Health
13.1.1 Cardinal Health Company Information
13.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Offered
13.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Cardinal Health Main Business Overview
13.1.5 Cardinal Health Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Offered
13.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Curium Pharma
13.3.1 Curium Pharma Company Information
13.3.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Offered
13.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Curium Pharma Main Business Overview
13.3.5 Curium Pharma Latest Developments
13.4 Jubilant Pharma
13.4.1 Jubilant Pharma Company Information
13.4.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Offered
13.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Jubilant Pharma Main Business Overview
13.4.5 Jubilant Pharma Latest Developments
13.5 Bracco Imaging
13.5.1 Bracco Imaging Company Information
13.5.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Offered
13.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bracco Imaging Main Business Overview
13.5.5 Bracco Imaging Latest Developments
13.6 Advanced Accelerator Applications
13.6.1 Advanced Accelerator Applications Company Information
13.6.2 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Offered
13.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Advanced Accelerator Applications Main Business Overview
13.6.5 Advanced Accelerator Applications Latest Developments
13.7 SIEMENS
13.7.1 SIEMENS Company Information
13.7.2 SIEMENS Diagnostic Radiopharmaceuticals Product Offered
13.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 SIEMENS Main Business Overview
13.7.5 SIEMENS Latest Developments
13.8 China Isotope & Radiation
13.8.1 China Isotope & Radiation Company Information
13.8.2 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Offered
13.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 China Isotope & Radiation Main Business Overview
13.8.5 China Isotope & Radiation Latest Developments
13.9 Dongcheng Pharmaceutical Group
13.9.1 Dongcheng Pharmaceutical Group Company Information
13.9.2 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Offered
13.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Dongcheng Pharmaceutical Group Main Business Overview
13.9.5 Dongcheng Pharmaceutical Group Latest Developments
13.10 Lantheus
13.10.1 Lantheus Company Information
13.10.2 Lantheus Diagnostic Radiopharmaceuticals Product Offered
13.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Lantheus Main Business Overview
13.10.5 Lantheus Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Offered
13.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Diagnostic Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Diagnostic Radiopharmaceuticals Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Technetium 99
Table 4. Major Players of Fluorine 18
Table 5. Major Players of Other
Table 6. Global Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 7. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue by Type (2017-2022) & ($ million)
Table 9. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Table 10. Global Diagnostic Radiopharmaceuticals Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 12. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 13. Global Diagnostic Radiopharmaceuticals Revenue by Application (2017-2022)
Table 14. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2017-2022)
Table 15. Global Diagnostic Radiopharmaceuticals Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Diagnostic Radiopharmaceuticals Sales by Company (2020-2022) & (K Units)
Table 17. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2022)
Table 18. Global Diagnostic Radiopharmaceuticals Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
Table 20. Global Diagnostic Radiopharmaceuticals Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 22. Players Diagnostic Radiopharmaceuticals Products Offered
Table 23. Diagnostic Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Diagnostic Radiopharmaceuticals Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Diagnostic Radiopharmaceuticals Sales Market Share Geographic Region (2017-2022)
Table 28. Global Diagnostic Radiopharmaceuticals Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Diagnostic Radiopharmaceuticals Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Diagnostic Radiopharmaceuticals Sales Market Share by Country/Region (2017-2022)
Table 32. Global Diagnostic Radiopharmaceuticals Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Diagnostic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 35. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 36. Americas Diagnostic Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 38. Americas Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 39. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 40. Americas Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 41. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 42. APAC Diagnostic Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 43. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Table 44. APAC Diagnostic Radiopharmaceuticals Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
Table 46. APAC Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 47. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 48. APAC Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 49. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 50. Europe Diagnostic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 51. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 52. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 54. Europe Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 55. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 56. Europe Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 57. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Diagnostic Radiopharmaceuticals
Table 67. Key Market Challenges & Risks of Diagnostic Radiopharmaceuticals
Table 68. Key Industry Trends of Diagnostic Radiopharmaceuticals
Table 69. Diagnostic Radiopharmaceuticals Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Diagnostic Radiopharmaceuticals Distributors List
Table 72. Diagnostic Radiopharmaceuticals Customer List
Table 73. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Diagnostic Radiopharmaceuticals Sales Market Forecast by Region
Table 75. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Diagnostic Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Diagnostic Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Diagnostic Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Diagnostic Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Diagnostic Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Application (2023-2028)
Table 93. Cardinal Health Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Cardinal Health Diagnostic Radiopharmaceuticals Product Offered
Table 95. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Cardinal Health Main Business
Table 97. Cardinal Health Latest Developments
Table 98. GE Healthcare Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. GE Healthcare Diagnostic Radiopharmaceuticals Product Offered
Table 100. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. GE Healthcare Main Business
Table 102. GE Healthcare Latest Developments
Table 103. Curium Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Curium Pharma Diagnostic Radiopharmaceuticals Product Offered
Table 105. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Curium Pharma Main Business
Table 107. Curium Pharma Latest Developments
Table 108. Jubilant Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Offered
Table 110. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Jubilant Pharma Main Business
Table 112. Jubilant Pharma Latest Developments
Table 113. Bracco Imaging Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. Bracco Imaging Diagnostic Radiopharmaceuticals Product Offered
Table 115. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Bracco Imaging Main Business
Table 117. Bracco Imaging Latest Developments
Table 118. Advanced Accelerator Applications Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Offered
Table 120. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Advanced Accelerator Applications Main Business
Table 122. Advanced Accelerator Applications Latest Developments
Table 123. SIEMENS Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 124. SIEMENS Diagnostic Radiopharmaceuticals Product Offered
Table 125. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. SIEMENS Main Business
Table 127. SIEMENS Latest Developments
Table 128. China Isotope & Radiation Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 129. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Offered
Table 130. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. China Isotope & Radiation Main Business
Table 132. China Isotope & Radiation Latest Developments
Table 133. Dongcheng Pharmaceutical Group Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 134. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Offered
Table 135. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Dongcheng Pharmaceutical Group Main Business
Table 137. Dongcheng Pharmaceutical Group Latest Developments
Table 138. Lantheus Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 139. Lantheus Diagnostic Radiopharmaceuticals Product Offered
Table 140. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Lantheus Main Business
Table 142. Lantheus Latest Developments
Table 143. Eli Lilly Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 144. Eli Lilly Diagnostic Radiopharmaceuticals Product Offered
Table 145. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Eli Lilly Main Business
Table 147. Eli Lilly Latest Developments
List of Figures
Figure 1. Picture of Diagnostic Radiopharmaceuticals
Figure 2. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diagnostic Radiopharmaceuticals Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Diagnostic Radiopharmaceuticals Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Technetium 99
Figure 10. Product Picture of Fluorine 18
Figure 11. Product Picture of Other
Figure 12. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2021
Figure 13. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Figure 14. Diagnostic Radiopharmaceuticals Consumed in Oncology
Figure 15. Global Diagnostic Radiopharmaceuticals Market: Oncology (2017-2022) & (K Units)
Figure 16. Diagnostic Radiopharmaceuticals Consumed in Cardiology
Figure 17. Global Diagnostic Radiopharmaceuticals Market: Cardiology (2017-2022) & (K Units)
Figure 18. Diagnostic Radiopharmaceuticals Consumed in Other
Figure 19. Global Diagnostic Radiopharmaceuticals Market: Other (2017-2022) & (K Units)
Figure 20. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Figure 21. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application in 2021
Figure 22. Diagnostic Radiopharmaceuticals Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company in 2021
Figure 24. Global Diagnostic Radiopharmaceuticals Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Geographic Region in 2021
Figure 26. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Figure 27. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Country/Region in 2021
Figure 28. Americas Diagnostic Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 29. Americas Diagnostic Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 30. APAC Diagnostic Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 31. APAC Diagnostic Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 32. Europe Diagnostic Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 33. Europe Diagnostic Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Diagnostic Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 36. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 37. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 38. United States Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2021
Figure 43. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Regions in 2021
Figure 44. China Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 51. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 52. Germany Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 59. Egypt Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Diagnostic Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals in 2021
Figure 65. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 66. Industry Chain Structure of Diagnostic Radiopharmaceuticals
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
